Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy
- 1 August 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (8) , 1193-1197
- https://doi.org/10.1016/0360-3016(87)90194-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogsInternational Journal of Radiation Oncology*Biology*Physics, 1987
- A phase i study of intravenous iododeoxyuridine as a clinical radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdRInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The use of halogenated thymidine analogs as clinical radiosensitizers: Rationale, current status, and future prospects: Non-hypoxic cell sensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1984
- A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radiation Enhancement with Iodinated DeoxyuridineInvestigative Radiology, 1982
- Effect of Absorption Edge Filters on Diagnostic X-Ray SpectraRadiology, 1975
- Inactivation of Mammalian Cells after Disintegrations of3H or125I in Cell DNA at −196°CInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1973
- GENETICS OF HUMAN CELL LINESThe Journal of Experimental Medicine, 1960
- Studies on Ultraviolet Irradiation of Escherichia coli Containing 5-Bromouracil in its DNAJournal of General Microbiology, 1960